Related content

Trends in the treatment of ductal carcinoma in situ of the breast

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 141-142

Informa Healthcare

Access to resources Recommend Favorite

Fluorescence in situ hybridization of metaphase chromosomes in suspension

By He H.   Deng W.   Cassel M. J.   Lucas J. N.  

International Journal of Radiation Biology, Vol. 77, Iss. 7, 2001-07 ,pp. : 787-795

Informa Healthcare

Access to resources Recommend Favorite

In Situ Protein Expression of RRM1, ERCC1, and BRCA1 in Metastatic Breast Cancer Patients Treated with Gemcitabine-Based Chemotherapy

By Metro G.   Zheng Z.   Fabi A.   Schell M.   Antoniani B.   Mottolese M.   Monteiro A. N.   Vici P.   Lara Rivera S.   Boulware D.   Cognetti F.   Bepler G.  

Cancer Investigation, Vol. 28, Iss. 2, 2009-09 ,pp. : 172-180

Informa Healthcare

Access to resources Recommend Favorite

Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab

By Dybdal Noël   Leiberman Grazyna   Anderson Steven   McCune Bryan   Bajamonde Alex   Cohen Robert   Mass Robert   Sanders Corsee   Press Michael  

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-09 ,pp. : 3-11

Springer Publishing Company

Access to resources Recommend Favorite

Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status

By Lee Hoon   Buchholz Thomas  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 55-56

Informa Healthcare

Access to resources Recommend Favorite